For further notes on methodology, as well as to see our analysis of the data, please see the corresponding report under the 'Arguments' tab: Pharmaceutical Patent Grants in India: How our safeguards against evergreening have failed, and why the system must be reformed.
For further notes on methodology, as well as to see our analysis of the data, please see the corresponding report under the 'Arguments' tab: Pharmaceutical Patent Grants in India: How our safeguards against evergreening have failed, and why the system must be reformed.
For further notes on methodology, as well as to see our analysis of the data, please see the corresponding report under the 'Arguments' tab: Pharmaceutical Patent Grants in India: How our safeguards against evergreening have failed, and why the system must be reformed.
For further notes on methodology, as well as to see our analysis of the data, please see the corresponding report under the 'Arguments' tab: Pharmaceutical Patent Grants in India: How our safeguards against evergreening have failed, and why the system must be reformed.
For further notes on methodology, as well as to see our analysis of the data, please see the corresponding report under the 'Arguments' tab: Pharmaceutical Patent Grants in India: How our safeguards against evergreening have failed, and why the system must be reformed.